20316 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole Isoindoles, e.g. phthalimide
Compositions for the treatment of hypertension
#302Amorphous Tecovirimat preparation
#303Therapeutic agents
#304Substituted amino six-membered saturated heteroalicycles as long-acting DPP-IV inhibitors
#305Inhibitors of histone deacetylase
#306Isoindoline compositions and methods for treating neurodegenerative disease
#307COMPOSITIONS AND METHODS OF TREATING CANCER
#308Compositions and methods of treating cancer
#309ALPHA-CINNAMIDE COMPOUNDS AND COMPOSITIONS AS HDAC8 INHIBITORS
#310Histone acetyltransferase activators and compositions and uses thereof
#311INHIBITORS OF HISTONE DEACETYLASE
#312Method of producing enriched exosomes
#313NITROGEN-CONTAINING HETEROCYCLIC COMPOUND
#314NOVEL COMPOUND AND ANTIVIRAL AGENT CONTAINING SAME AS ACTIVE INGREDIENT
#315Carbazole and tetrahydrocarbazole compounds useful as inhibitors of BTK
#316Use of NK-1 receptor antagonists in pruritus
#317Use of NK-1 receptor antagonist serlopitant in pruritus
#318Compositions and methods for treating severe pain
#319Isoindoline derivatives
#320Materials and methods to enhance hematopoietic stem cells engraftment procedures
#321Quinoline derivative against non-small cell lung cancer
#322Stable apremilast crystalline form II free of solvate and method of making the same
#323Composite preparation, containing novel 3-(4--(benzyloxy)phenyl)hex-4-inoic acid derivative and another active ingredient, for preventing or treating metabolic diseases
#324BENZO-HETEROCYCLIC COMPOUNDS AND THEIR APPLICATIONS
#325Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
#326Capsazepine analogs for the treatment of cancer and other proliferative diseases
#327Therapeutic and research application of PDCL3
#328Active metabolite of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate monohydrate and dimesylate dihydrate salt of active metabolite
#329Nitrogen-containing heterocyclic compound
#330Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C
#331Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
#332Nitrogen-containing heterocyclic compound
#333Nampt Inhibitors
#334COMPOSITIONS AND METHODS FOR IDENTIFYING AND TREATING CONDITIONS INVOLVING HSF1 ACTIVITY
#335Amorphous tecovirimat preparation
#336INHIBITORS OF HISTONE DEACETYLASE
#337Nitrogen-containing heterocyclic compound
#338Compounds
#339Pharmaceutical formulation comprising losartan potassium and chlorthalidone
#340Modulators of chemokine receptors
#341Inhibitors of CXCR2
#342Crystalline forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
#343Apremilast for the treatment of a liver disease or a liver function abnormality
#344TREATMENT OF MALARIA USING INHIBITORS OF THE ISPD ENZYME IN THE NON-MEVALONATE PATHWAY
#345Compounds and methods for inducing chondrogenesis
#346Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation
#347Prodrugs of Succinic Acid for Increasing ATP Production
#348Nitrogen-containing heterocyclic compound
#349Methods for treating inflammatory and other diseases and the use of biomarkers as predictors of clinical sensitivity to treatment with apremilast
#350Methods and compounds to inhibit enveloped virus release
#351Composition including indoprofen and use thereof
#352COMPOSITIONS AND METHODS FOR THE TREATMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASES WITH PDE4 MODULATORS
#353Insulin sensitisers and methods of treatment
#354Use of NK-1 receptor antagonists in pruritus
#355Use of NK-1 receptor antagonist serlopitant in pruritus
#356Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimer's disease
#357LPA RECEPTOR MODULATORS FOR BROWN FAT DIFFERENTIATION
#358Nitrogen-containing heterocyclic compound
#359Isoindolinone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
#360Use of NK-1 receptor antagonists for treating hypomagnesemia, neurogenic inflammation, and cardiac dysfunction associated with EGFR-blocking drugs
#361Medicament for suppressing malignant tumor metastasis
#362Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers
#363Sigma receptor ligands and methods of modulating cellular protein homeostasis using same
#364THERAPEUTIC AGENTS
#365Inhibitors of histone deacetylase
#366Material and methods for treating developmental disorders including comorbid and idiopathic autism
#367COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL DISEASES WITH PDE4 MODULATORS
#368Use of NK-1 receptor antagonists in pruritus
#369Compounds and methods for the enhanced degradation of targeted proteins
#370Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
#371Methods for treating newly diagnosed multiple myeloma with 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with second active agents
#372Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
#373Inhibitors of histone deacetylase
#374Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
#375Rehydration of micronized tecovirmimat monohydrate
#376KCNQ channels as therapeutic targets
#377MONOMETHYLFUMARATE PRODRUG COMPOSITIONS
#378Triple reuptake inhibitors and methods of their use
#379Tetrahydrocyclopentapyrrole derivatives and a method for preparing the same
#380Bispecific CD33 and CD3 binding proteins
#381Method of treatment for mental disorders
#382BENZAMIDE DERIVATIVES AND THEIR USE AS HSP90 INHIBTORS
#383Amorphous tecovirimat preparation
#384Cooperative Medication Combination Systems
#385THERAPIES FOR DISEASES CAUSED BY ARTHROPOD-BORNE PARASITES
#386Combination therapies for malaria
#387Methods of using (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
#388Use of NK-1 receptor antagonist serlopitant in pruritus
#389Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
#390Cyclopropaneamine compound
#391Method of treatment for mental disorders
#392Controlled release oral dosage forms of poorly soluble drugs and uses thereof
#393ST-246 liquid formulations and methods
#394Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C
#395SCREENING METHOD AND COMPOUNDS FOR MODULATING TELOMERASE ACTIVITY
#396Compounds and methods for inducing chondrogenesis
#397Methods for the treatment of diseases ameliorated by PDE4 inhibition using dosage titration of apremilast
#398Use of NK-1 receptor antagonists in pruritus
#399Compounds for inducing proliferation and differentiation of cells, and methods of use thereof
#400Nampt Inhibitors
#401Materials and methods to enhance hematopoietic stem cells engraftment procedures
#402Stable Pharmaceutical Package Comprising Azilsartan Medoxomil
#403Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies
#404Acylguanidines for treating osteoarthritis
#405Use of NK-1 receptor antagonists for treating hypomagnesemia, neurogenic inflammation, and cardiac dysfunction associated with EGFR-blocking drugs
#406Use of PDE4 inhibitors and combinations thereof for the treatment of cystic fibrosis
#407COMPOSITION
#408Amine derivative or salt thereof
#409Methods and compositions for targeting cancer stem cells
#410Methods of treating muscular dystrophy
#411INTRACELLULAR KINASE INHIBITORS
#412Pro-neurogenic compounds
#413METHODS FOR THE TREATMENT OF BONE LOSS
#414Amorphous form of apremilast
#415METHODS FOR TREATING SPINAL MUSCULAR ATROPHY
#4164-carboxamido-isoindolinone derivatives as selective PARP-1 inhibitors
#417Treatment of Cancer with Glufosfamide in Patients Not Receiving Insulin Therapy
#418Fixed Dosage Formulations of Angiotensin Converting Enzyme (ACE) inhibitor and the Diuretic Chlorthalidone
#419Nanosuspension of a poorly soluble drug via microfluidization process
#420Isotopologues of isoindole derivatives
#421Perforin inhibiting benzenesulfonamide compounds, preparation and uses thereof
#422METHODS FOR THE TREATMENT OF OBESITY USING APREMILAST
#423Method of treating and preventing brain impairment using Na-K-2Cl-cotransporter isoform 1 inhibitors
#424Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
#425Formulations of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide
#426Isoindolin-1-ones as macrophage migration inhibitory factor (MIF) inhibitors
#427Heteroaryl compounds and uses thereof
#428METHODS FOR THE TREATMENT OF PSORIATIC ARTHRITIS USING APREMILAST
#429Sigma receptor ligands and methods of modulating cellular protein homeostasis using same
#430Cyclic amino compounds for use in the treatment of cardiac disorders
#431Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control
#432METHODS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTION OR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#433ISOINDOLONE DERIVATIVES
#434METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C
#435Methods for treating non-hodgkin's lymphoma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with a second active agent
#436Method of modulating ribonucleotide reductase
#437Use of NK-1 receptor antagonists in pruritus
#438Cyclic amides as MetAP-2 inhibitors
#439COMBINATION OF LIVER X RECEPTOR MODULATOR AND ESTROGEN RECEPTOR MODULATOR FOR THE TREATMENT OF AGE-RELATED DISEASES
#440Methods and compositions for treatment of muscle wasting, muscle weakness, and/or cachexia
#441Pharmaceutical composition comprising candesartan or ester thereof and chlortalidone, and use thereof
#442Use of NK-1 receptor antagonists in pruritus
#443Methods for treating newly diagnosed multiple myeloma 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with dexamethasone
#444Materials and methods to enhance hematopoietic stem cells engraftment procedures
#445Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
#446Formulations of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
#447HCV NS3 protease inhibitors
#448HCV protease inhibitors and uses thereof
#449Compounds, compositions and methods for treatment and prevention of infections and associated diseases
#450Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation
#451KCNQ channels as therapeutic targets
#452Methods for the treatment of psoriatic arthritis using apremilast
#453Crystalline forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
#454COMPOSITION FOR DELIVERY OF ANGIOGENESIS INDUCING MOLECULE AND ARTIFICIAL TISSUE PREPARED BY THE COMPOSITION
#455Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists
#456Substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C
#457Compounds and methods for inducing chondrogenesis
#458COMPOSITIONS AND METHODS FOR TREATING HERPES VIRUSES
#459DIHYDROFURAN DERIVATIVES AS INSECTICIDAL COMPOUNDS
#460Cyclopropaneamine compound
#461Vaccine composition
#462Methods for treating non-hodgkin's lymphoma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a second active agent
#463Methods for treating amyloidosis with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
#464Combinations with 2-aminoethanesulfonic acid
#465Therapeutic agents
#466Isotopologues of isoindole derivatives
#467Methods for treating diseases using isoindoline compounds
#468Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione in combination with antibodies
#469Molecules inhibiting a metabolic pathway involving the Syk protein tyrosine kinase and method for identifying said molecules
#470METHODS AND COMPOUNDS TO INHIBIT ENVELOPED VIRUS RELEASE
#471Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
#472Pharmaceutical compositions and treatment of genetic diseases associated with nonsense mediated RNA decay
#473Oral dosage forms of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide
#474Compounds for the treatment of autism in a baby child
#475Methods of treating muscular dystrophy
#476COMPOUNDS CONTAINING AN ALICYCLIE STRUCTURE AND ANTI-TUMOR APPLICATION
#477Methods of treating arthritic conditions using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione
#478ST-246 liquid formulations
#479Insulin sensitisers and methods of treatment
#480METHODS FOR THE TREATMENT OF SARCOIDOSIS
#481Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
#482COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN AND OTHER DISEASES
#483Modulation of ubiquitination of synaptic proteins for the treatment of neurodegenerative and psychiatric disorders
#484Tetrahydroisoquinoline derivative
#485Matrix metalloproteinase inhibitors
#486Matrix metalloproteinase inhibitors
#487Isoindolone derivatives
#488Substituted N-(2-arylamino)aryl sulfonamide-containing combinations
#489COMBINATIONS OF MEDICAMENTS, CONTAINING PDE4-INHIBITORS AND EP4-RECEPTOR-ANTAGONISTS
#490Non peptidic 14-3-3 inhibitors and the use thereof
#491THALIDOMIDE AND THALIDOMIDE ANALOGUES FOR THE PREVENTION AND TREATMENT OF SARCOPENIA
#492Di-azetidinyl diamide as monoacylglycerol lipase inhibitors
#493Di-azetidinyl diamide as monoacylglcerol lipase inhibitors
#494Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C
#495FORMULATIONS OF (+)-2-[1-(3-ETHOXY-4-METHOXY-PHENYL)-2-METHANESULFONYL-ETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE
#496METHODS FOR TREATING HYPERTENSION IN BLACK PATIENTS
#497METHODS FOR INHIBITION OF CELL PROLIFERATION, SYNERGISTIC TRANSCRIPTION MODULES AND USES THEREOF
#498CHLORTHALIDONE COMBINATIONS
#499Methods for treating respiratory viral infection
#500Methods of treating cancer using a combination of an immunomodulatory compound and an artemisinin or a derivative thereof
#501METHOD FOR THE PREPARATION OF CIS-1,2-DIOLS IN THE KILOGRAM SCALE
#5022-PHENYL BENZOYLAMIDES
#503KALLIKREIN 7 MODULATORS
#504Compounds for the treatment of autism
#505Method of treatment for mental disorders
#506Methods of reducing virulence in bacteria
#507Screening method and compounds for modulating telomerase activity
#508Methods and compositions using PDE4 inhibitors for the treatment and management of autoimmune and inflammatory diseases
#509INHIBITION OF P38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
#510Treatment And Prognosis With Thalidomide In Multiple Myeloma Based on Karyotyping And Gene Expression Profiling
#511BRCA1-based breast or ovarian cancer treatment agents and methods of use
#512AGENT FOR TREATING FIBROMYALGIA
#513Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with proteasome inhibitor
#514Methods for treating amyloidosis using 4-(amino)-2-(2,6-Dioxo(3-piperidyl))- isoindoline-1,3-dione
#515PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF RESPIRATORY AND INFLAMMATORY DISEASES
#516Therapeutic Inhibitor of Vascular Smooth Muscle Cells
#517IMMUNOLOGICAL USES OF IMMUNOMODULATORY COMPOUNDS FOR VACCINE AND ANTI-INFECTIOUS DISEASE THERAPY
#518Phenethylsulfone isoindoline derivatives and their use
#519METHODS FOR TREATMENT OF MULTIPLE MYELOMA USING CYCLOPROPANE CARBOXYLIC ACID {2-(Is)-(3-eTHOXY-4METHOXY-PHENYL)-2-METHANESULFONYL-ETHYL}-3-OXO-2.3-DIHYDRO-1H-ISOINDOL-4-YL}-AMIDE
#520METHODS OF USING AND COMPOSITIONS COMPRISING PDE4 MODULATORS FOR TREATMENT, PREVENTION AND MANAGEMENT OF TUBERCULOSIS
#521Specific HCV NS3 protease inhibitors
#522Method of treatment for mental disorders
#523Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
#524Positive allosteric modulators of group II mGluRs
#525Methods of treating mild cognitive impairment (MCI) and related disorders
#526DI-AZETIDINYL DIAMIDE AS MONOACYLGLYCEROL LIPASE INHIBITORS
#527LEVAMLODIPINE COMPOUND PHARMACEUTICAL COMPOSITION
#528Compounds and methods for treating cancer and viral infections
#529METHODS OF TREATING MULTIPLE MYELOMA USING MELPHALAN, PREDNISONE AND LENALIDOMIDE
#530Oxo-heterocyclically substituted alkyl carboxylic acids and use thereof
#531Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
#532Material and methods for treating developmental disorders including comorbid and idiopathic autism
#533Materials and methods to enhance hematopoietic stem cells engraftment procedures
#534Estrogen receptor modulators and uses thereof
#535Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity
#536Triple reuptake inhibitors and methods of their use
#537Therapeutic Inhibitor of Vascular Smooth Muscle Cells
#538Compositions and methods for treating amyloidosis
#539INTRACELLULAR KINASE INHIBITORS
#540ANTIOXIDANT COMPOUNDS AND METHODS OF THEIR USE
#541Antiprolactinic veterinary composition for ruminants
#542Compounds and methods for the treatment of pain and other diseases
#543Therapeutic agents
#544METHODS FOR TREATING OR SCREENING FOR COMPOUNDS FOR THE TREATMENT OF SEPSIS
#545Screening assays for compounds that modulate programmed ribosomal frameshifting
#546Organosulfur compounds, a method of making organosulfur compounds and their use for inhibiting the growth of tumour cells
#547Methods and compositions for the treatment of obesity
#548Methods for treating spinal muscular atrophy
#549NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#550Nanosuspension of a poorly soluble drug via microfluidization process
#551Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses
#552Solid forms comprising (+)-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisinoline-1,3-dione, compositions thereof, and uses thereof
#553MOLECULES INHIBITING A METABOLIC PATHWAY INVOLVING THE SYK PROTEIN TYROSINE KINASE AND METHOD FOR IDENTIFYING SAID MOLECULES
#554Aminocarboxylic acid derivative and medicinal use thereof
#555METHODS FOR TREATING CUTANEOUS LUPUS USING AMINOISOINDOLINE COMPOUNDS
#556New Compounds
#557NPY Y5 ANTAGONIST
#558Pro-neurogenic compounds
#559Insulin sensitisers and methods of treatment
#560NPY Y5 antagonist
#561Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
#562PHARMACEUTICAL COMPOSITION
#563Methods for treatment of hepatocellular carcinoma using 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
#564Kallikrein 7 modulators
#565Pyrrolidine compounds
#566LIQUID AND SEMI-SOLID PHARMACEUTICAL FORMULATIONS FOR ORAL ADMINISTRATION OF A SUBSTITUTED AMIDE
#567Methods for treatment of follicular lymphoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
#568Pharmaceutical combinations
#569Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione
#570TRBD-binding effectors and methods for using the same to modulate telomerase activity
#571Estrogen receptor modulators and uses thereof
#572METHODS AND COMPOSITIONS USING PDE4 INHIBITORS FOR THE TREATMENT AND MANAGEMENT OF CANCERS
#573Treatment of cancer with glufosfamide in patients not receiving insulin therapy
#574Methods and Compositions Using Immunomodulatory Compounds for The Treatment and Management of Cancers and Other Diseases
#575Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a proteasome inhibitor
#576Pharmaceutical combinations
#577Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#578Matrix metalloproteinase inhibitors
#579METHODS FOR TREATMENT OF COLORECTAL CANCER USING 3-(4-AMINO-1-OXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE
#580Remedy for angiospasm accompanying subarachnoid hemorrhage containing thrombin receptor antagonist as the active ingredient
#581ORAL DISINTEGRATING TABLET HAVING MASKED BITTER TASTE AND METHOD FOR PRODUCTION THEREOF
#582Pharmaceutical compounds
#583Aminocarboxylic acid derivative and medicinal use thereof
#584Combination therapy for the treatment of urinary frequency, urinary urgency and urinary incontinence
#585METHODS FOR THE TREATMENT OF PSORIASIS OR PSORIATIC ARTHRITIS USING CYCLOPROPYL-N-CARBOXAMIDE
#586COMBINATIONS OF METFORMIN AND MEGLITINIDE
#587Method of inhibiting neurotrophin-receptor binding
#588Process for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives
#589THERAPEUTIC INHIBITOR OF VASCULAR SMOOTH MUSCLE CELLS
#590HCV protease inhibitors and uses thereof
#591BRCA1-BASED BREAST OR OVARIAN CANCER PREVENTION AGENTS AND METHODS OF USE
#592Method for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with antibodies
#593Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses
#594METHODS FOR THE TREATMENT OF BLADDER CANCER USING 3-(4-AMINO-1-OXO-1,3-DIHYDROISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE
#595OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
#596Use of compounds for the prevention of drug-induced cell toxicity
#597Chlorthalidone combinations
#598Compositions and methods for treating amyloidosis
#599INHIBITION OF P38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
#600C-glycoside derivatives and salts thereof